جستجوی استاد راهنمای دانشگاهی

Dr. Tong Sun is an Assistant Professor of Pathology at Yale School of Medicine, specializing in surgical pathology and cytopathology with a focus on gynecological and genitourinary pathology. Her research emphasizes translational and molecular studies in cancer diagnostics, including the application of next-generation sequencing and molecular markers in cytology. Education & Training: M.D. from Peking University Health Science Center (2002) Ph.D. in Molecular Oncology from Peking Union Medical College (2007) Postdoctoral Research Fellow at Dana-Farber Cancer Institute (2011) Clinical and Anatomic Pathology Residency at University of Massachusetts Medical School (2019) Cytopathology Fellowship at Massachusetts General Hospital (2020) Research Interests: Dr. Sun’s work bridges clinical practice and research, focusing on improving diagnostic accuracy through molecular profiling and cytological techniques. Key areas include: Genetic markers in castration-resistant prostate cancer Application of the Paris and International Systems for Urine/Serous Fluid Cytopathology Next-generation sequencing in urothelial and gynecologic malignancies Cytomorphologic challenges in transgender health and histological correlation Publications & Trends: Over 50 peer-reviewed articles and 5 book chapters, highlighting advancements in cervical cytology, thyroid nodules, endometrial cancer prognosis, and ovarian cyst diagnostics. Recent work emphasizes molecular features of pancreatic and lung carcinomas. Awards: Warren R. Lang Resident Physician Award (2020) Journal of American Society of Cytopathology Physician-in-training Award (2022) Grants & Labs: Collaborates with Yale’s Gelb Genitourinary Translation Research Center and frequently publishes with co-authors like Guoping Cai and Adebowale Adeniran. No specific lab mentioned, but active in interdisciplinary cancer research teams. Future Work: Expanding studies on KRAS mutations in biliary stenosis, SMARCA4-deficient lung carcinomas, and clinical validation of novel diagnostic tools in serous fluid cytology.

• Cytopathology
• Molecular Oncology
• Genitourinary Pathology
• +۳ مورد دیگر

Steven B. Smith is the Alfred Cowles Professor of Political Science at Yale University, where he has taught since 1984. His academic career includes leadership roles such as Director of Graduate Studies in Political Science, Director of the Special Program in the Humanities, and Acting Chair of Judaic Studies. Research focuses on the history of political philosophy Special attention to the ancients vs. moderns, religion and politics, and theories of representative government The 14 listed publications span 2014-2025 and include topics in pathology, oncology, and medical diagnostics, though their relevance to Smith's political science expertise remains unclear. His teaching includes the acclaimed course Introduction to Political Philosophy , and he has received awards such as the Lex Hixon '63 Prize for Teaching Excellence (2009). Ralph Waldo Emerson Prize from Phi Beta Kappa Lex Hixon '63 Prize for Teaching Excellence (2009)

• Political Philosophy
• History of Political Thought
• Ancients vs. Moderns
• +۳ مورد دیگر

Anton Pottegård is a Professor at the University of Southern Denmark and Head of Research at Hospital Pharmacy Funen (Odense University Hospital). His work combines registry-based pharmacoepidemiological research with clinical investigations into deprescribing practices. Affiliation: University of Southern Denmark Secondary Role: Head of Research, Odense University Hospital Research interests focus on pharmacoepidemiology and clinical pharmacy , particularly real-world drug safety and deprescribing in geriatric care. His methodology emphasizes Danish healthcare registries for longitudinal analyses of medication patterns and adverse outcomes. Notable contributions include epidemiological analyses of opioid utilization , migraine treatments , and GLP-1 receptor agonists . He has developed frameworks for pharmacoepidemiological methodology and drug safety surveillance , co-authored over 300 publications, and led the REDO project on reducing opioid use in osteoarthritis. Additional activities include media commentary on TBE vaccination and tick-borne diseases , with 613 press/media appearances reflecting public health engagement. Supervised work includes 7 doctoral candidates and cross-national collaborations.

• Pharmacoepidemiology
• Clinical Pharmacy
• Drug Utilization
• +۴ مورد دیگر

Gregory T. MacLennan, MD is a Professor in the Department of Pathology and Department of Urology at the School of Medicine, Case Western Reserve University (CWRU), and a Physician at University Hospitals Cleveland Medical Center (UHCMC). He earned his MD from the University of Manitoba in 1971 and completed surgical and urology training in Canada and a urodynamics fellowship in the UK. After clinical practice in urology, he transitioned to anatomic pathology, completing further training at Mayo Clinic. Education: MD, University of Manitoba (1971) Fellowship in Urodynamics, St. Peter’s Hospitals, London (1977–1978) Training in Anatomic Pathology & Cytopathology, Manitoba Affiliated Teaching Hospitals (1989–1994) Fellowship in Surgical/Urologic Pathology, Mayo Clinic (1994–1995) Research Interests: Dr. MacLennan specializes in genitourinary pathology, focusing on diagnostic surgical and cytopathology. His work integrates clinical and basic science collaborations, addressing urogenital and reproductive system pathologies. Key areas include tumors like liposarcoma, renal pseudotumors, and urachal adenocarcinoma, emphasizing multidisciplinary approaches with urologists, oncologists, and radiologists. Key Roles: Director of Human Tissue Procurement Facility (17 years) Director of Surgical Pathology (8 years) Division Chief of Anatomic Pathology (7 years) Editorial Board Member, Journal of Urology (7 years) Awards: 2015: Inducted into CWRU Urology Department Hall of Fame Specialist Certification: Royal College of Physicians and Surgeons of Canada Board Certification: American Boards of Urology and Pathology Labs & Collaborations: Collaborates with clinical and basic science teams across UHCMC and CWRU, contributing to advancements in diagnostic and molecular pathology.

• Genitourinary Pathology
• Surgical Pathology
• Cytopathology
• +۳ مورد دیگر

Katie L. Dennis, M.D. serves as an Associate Professor in the Department of Pathology and Laboratory Medicine at the University of Kansas School of Medicine. Board certified in Anatomic and Clinical Pathology and Cytopathology by the American Board of Pathology, she holds active medical licenses in Kansas and Missouri. Dr. Dennis leads the Autopsy division of the Abstract review board for the United States and Canadian Academy of Pathology (2019-Present), previously served as President of the Kansas City Society of Pathologists (2013-2014), and maintains membership in the American Society for Clinical Pathology (2009-Present). Her research program centers on genitourinary pathology, liver pathology, and cytopathology, with significant emphasis on resident education methodologies. Clinical investigations address diagnostic challenges across gastrointestinal/pancreatic pathology, breast pathology, and autopsy pathology, integrating molecular techniques to refine pathological assessments in diverse tissue specimens. Dr. Dennis's recent publications demonstrate a cohesive focus on diagnostic innovation in surgical pathology and cytology. Key trends include application of immunohistochemistry for pancreatic cancer subtyping, optimization of flow cytometry protocols for effusion specimens, standardization of respiratory tract cytology diagnostics, and exploration of hepatic oxidative injury mechanisms—collectively advancing precision in pathological diagnostics. She actively mentors medical students, pathology residents, and surgical/cytopathology fellows through structured curricula and hands-on clinical training. Dr. Dennis's educational leadership extends to her role on national pathology society review boards, where she shapes academic discourse and trainee development standards across the specialty.

• genitourinary pathology
• liver pathology
• cytopathology
• +۵ مورد دیگر

Dr. Arnold I. Chin is a Professor of Urology and Medical Director of Urology-Westwood at the David Geffen School of Medicine at UCLA. He completed both his MD and PhD at UCLA and completed his urology residency training there as well. His clinical expertise spans urologic oncology and renal transplantation, with specialization in open, laparoscopic, and robotic-assisted surgeries for bladder, kidney, and prostate cancer patients. Dr. Chin's educational background includes: MD, UCLA School of Medicine, 2003 PhD, UCLA, 2002 Internship in Surgery, UCLA School of Medicine, 2004 Residency in Urology, UCLA School of Medicine, 2009 Dr. Chin's research focuses on understanding cancer differentiation and its interplay with the tumor microenvironment. His laboratory investigates molecular mechanisms in programming tumor-infiltrating lymphocytes and mechanisms controlling development and differentiation of cancer stem cells. His work aims to develop novel therapeutic targets, immune-based platforms, and stem cell-directed therapies against cancer. He is affiliated with the Broad Stem Cell Research Center, Tumor Immunology Program Area, and Genitourinary Oncology Program Area of the Jonsson Comprehensive Cancer Center. His recent research has centered on bladder cancer, prostate cancer, renal cell carcinoma, and neuroendocrine carcinomas, with emphasis on tumor microenvironment, immunotherapy approaches, and molecular targets for cancer treatment. Dr. Chin has received several prestigious awards: Super Doctors® Southern California, 2022-2025 Super Doctors® Southern California Rising Stars 2018 STOP Cancer Research Career Development Award 2010 American Association of Cancer Research Career Development Award for Translational Cancer Research 2010 Dr. Chin is actively involved in mentoring students and research fellows in his laboratory, guiding them in cutting-edge cancer research. His work has been supported by various grants from organizations including STOP Cancer and the American Association of Cancer Research. He is also involved in clinical trials related to urologic cancers. Dr. Chin leads a translational research laboratory focused on tumor microenvironment in prostate and bladder cancer, using a combination of animal models, human reconstitution systems, and primary tumor and hematopoietic cells. His team is investigating molecular mechanisms in programming tumor-infiltrating lymphocytes and the development and differentiation of cancer stem cells.

• Urologic Oncology
• Renal Transplantation
• Cancer Stem Cell Research
• +۳ مورد دیگر

Priti Lal, MD, is an Associate Professor in the Department of Pathology and Laboratory Medicine at the University of Pennsylvania's Perelman School of Medicine. She serves as the Director of GU Pathology and is an Associate Scholar at the Center for Global Health. Her work bridges advanced pathology, AI-driven diagnostics, and global oncology, with a strong focus on improving cancer outcomes for men of African descent. Her research interests lie at the intersection of global oncology , medical education , and digital pathology . She specializes in bladder, kidney, and prostate cancers, applying cutting-edge computational image analysis to develop nondestructive, AI-based prognostic tools such as Histotyping and AAstro . These innovations aim to address disparities in prostate cancer outcomes by creating population-specific models for African American and African men. The recent publications highlight a strong trend in leveraging AI and genomics to uncover biologically distinct cancer pathways and improve risk stratification. Her work emphasizes stromal morphology and gland structure in prognostication, moving beyond traditional clinical parameters to enhance accuracy. Scientific recognition includes: Co-inventor of US Patent US20210035694A1 for an AI-derived stromal signature in prostate cancer Dr. Lal is deeply involved in global health mentorship, particularly through the MADCAP consortium—a collaborative network involving Harvard, Moffit, Penn, and ten African countries. She mentors students and trainees from Africa, promoting capacity building in molecular diagnostics and pathology education. While specific grant details are not listed, her leadership in international research initiatives suggests active grant-supported work. She leads pathology innovation at Penn and is a key figure in the MADCAP consortium, driving collaborative research and education across continents. Her lab focuses on translating AI-based image analysis into clinical tools for equitable cancer care.

• Global Oncology
• Prostate Cancer
• Bladder and Kidney Cancer
• +۷ مورد دیگر

Luis Alberto Velasquez Zarate is an Assistant Professor at the Medical College of Georgia, where he holds appointments in the Department of Pathology with a subspecialty focus in Anatomic Pathology. He is actively involved in clinical research and diagnostic pathology, contributing to advancements in cancer classification and molecular diagnostics. Research Interests: His work spans anatomic pathology with emphasis on rare tumors, cancer epidemiology using population databases, and molecular techniques in cytology and sarcoma diagnostics. Key areas include endocrine, gynecologic, and soft tissue pathology, with a strong methodological foundation in SEER database analysis and immunohistochemical validation. The recent publications highlight a consistent trend in utilizing large-scale epidemiological data (SEER) to analyze incidence and survival in rare malignancies, combined with deep dives into molecular markers such as YWHAE and NKX2.2 for diagnostic precision in sarcomas and the application of FISH in pancreatobiliary lesions. This reflects a dual focus on population health and precision pathology. Service: Committee Member, Society of Pediatric Pathology (2021–Present) Education: MD in Medicine, Universidad San Martin De Porr (2009) Certified by GA Composite Medical Board (2018, 2022) Dr. Velasquez Zarate’s research contributes significantly to the understanding of rare cancers and diagnostic innovation in surgical pathology. While no formal advisees or awards are listed, his scholarly output indicates active engagement in translational pathology research. He plays a service role in a national pathology society, suggesting professional integration and contribution to the specialty.

• Anatomic Pathology
• Surgical Pathology
• Cancer Epidemiology
• +۶ مورد دیگر

J. Kenneth Schoolmeester, II, M.D. is a Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Jacksonville, Florida, specializing in Anatomic Pathology with a focus on gynecologic pathology. He holds board certification in Anatomic Pathology from the American Board of Pathology and has established himself as a leading expert in uterine and ovarian tumors, sarcomas, and molecular pathology. Medical College of Virginia (MD) Mayo Clinic College of Medicine (Residency in Anatomic Pathology) Memorial Sloan Kettering Cancer Center (Fellowship in Oncologic Surgical Pathology) Dr. Schoolmeester's research spans gynecologic pathology with particular emphasis on soft tissue tumors of the female genital tract, molecular characterization of uterine and ovarian neoplasms, and diagnostic pathology of sarcomas. His work bridges traditional histopathology with cutting-edge molecular techniques to improve diagnostic accuracy and inform treatment approaches. He has made significant contributions to understanding leiomyomas, leiomyosarcomas, and rare gynecologic tumors through detailed clinicopathologic and molecular studies. Analysis of his recent publications reveals a strong focus on molecular characterization of gynecologic tumors, particularly examining genetic alterations in uterine sarcomas, leiomyomas with unusual features, and rare gynecologic malignancies. His work frequently employs advanced techniques including fluorescence in situ hybridization, next-generation sequencing, and immunohistochemical profiling to characterize tumor biology and improve diagnostic classification. Mayo Clinic Fellows' Association Teacher of the Year (2017) Arthur Purdy Stout Society Study Award (2012) Academic Merit Scholarship from Medical College of Virginia (2006) Intersociety Council for Pathology Information Travel Award (2001) Dr. Schoolmeester actively collaborates with multidisciplinary teams across Mayo Clinic and other institutions, contributing to significant research in gynecologic oncology and molecular pathology. His work has implications for diagnostic classification, risk stratification, and potential therapeutic targets for patients with gynecologic malignancies. He serves as a key resource for diagnostic pathology consultation, particularly for complex gynecologic cases requiring specialized expertise.

• Gynecologic Pathology
• Sarcoma Pathology
• Molecular Pathology
• +۳ مورد دیگر

Vinita Parkash is a Senior Research Scientist in Public Health (Health Policy) and Associate Clinical Professor of Pathology at Yale University. She holds affiliations with Yale School of Medicine, Yale Institute for Global Health, and Yale School of Public Health. Her expertise spans gynecological pathology, healthcare quality/safety, and diagnostic error reduction. Dr. Parkash completed her MBBS at Lady Hardinge Medical College and an MPH in Health Policy at Yale. She trained at Memorial Sloan Kettering Cancer Center and Yale-New Haven Hospital. Her research focuses on improving diagnostic accuracy and patient engagement in healthcare, particularly in low-resource settings. She has developed global guidelines for gynecological cancer diagnosis and abortion tissue processing, earning awards such as the CAP Distinguished Patient Care Award (2024) and NAM Scholars in Diagnostic Excellence (2023). Her work includes advancing AI-assisted pathology diagnostics, virtual education networks for gynecologic oncology, and WHO tumor classification updates. She teaches courses on healthcare quality at Yale and Quinnipiac University, and mentors global pathology fellows through initiatives like the International Gynecological Cancer Society’s virtual fellowship program. Dr. Parkash leads interdisciplinary efforts in patient safety, collaborating with the Betsy Lehman Center and AHRQ. Her contributions bridge clinical pathology, public health policy, and global health equity.

• Gynecological Pathology
• Healthcare Quality and Safety
• Cancer Diagnosis
• +۳ مورد دیگر

Joshua Warrick, MD is a Professor in the Department of Pathology and Laboratory Medicine and the Department of Urology at Pennsylvania State University College of Medicine. He serves as Chief of the Division of Anatomic Pathology. His research focuses on bladder cancer, carcinogenesis mechanisms, and molecular subtypes of urothelial tumors. Dr. Warrick has authored over 87 publications and led the National Cancer Institute-funded project on transcription factors in bladder cancer. Education: Medical Degree from Wayne State University (2007), followed by residencies in Internal Medicine (2008), Pathology (2009-2012), and a fellowship in Surgical & Genitourinary Pathology at the University of Michigan (2014). Research interests include bladder cancer pathogenesis, squamous differentiation in prostate cancer, and improving diagnostic standards for urothelial carcinomas. He received the 'Outstanding Collaborative Research Team' award in 2020 for multidisciplinary work in oncology. Advising and grants: Led a 2021-2023 NCI-funded project investigating transcription factors in non-invasive bladder cancer, with a focus on aggressive tumor phenotypes. Collaborates internationally on grading systems and diagnostic reproducibility in urologic pathology. Labs and teams: Active in the Penn State Cancer Institute’s 'Mechanisms of Carcinogenesis' unit, leveraging anatomic pathology expertise to advance translational oncology research.

• Bladder Cancer
• Carcinogenesis
• Urothelial Carcinoma
• +۵ مورد دیگر

Linda N. Dao, M.D. is a Clinical Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic College of Medicine and Science. She specializes in Hematopathology and Surgical Pathology with primary clinical focus at the Rochester, Minnesota campus. Her educational background includes: MD from Texas Tech University School of Medicine (2005) Bachelor of Arts from The University of Texas at Austin (2001) Residency in Anatomic and Clinical Pathology at Mayo Clinic (2009) Fellowships in Hematopathology (2011) and Surgical Pathology (2010) Dr. Dao's research centers on amyloidosis characterization using advanced proteomic techniques, with significant contributions to mass spectrometry-based amyloid typing. Her work spans multi-organ amyloid deposition including salivary glands, spleen, gastrointestinal tract, and bone marrow. Current investigations focus on developing minimally invasive lymphoma detection methods through blood plasma biomarkers. Analysis of her 15 most recent publications reveals a dominant focus on amyloidosis subtyping through proteomics (68% of articles), with emerging work in molecular diagnostics for hematologic malignancies. Key methodological trends include large-scale validation studies (>16,000 samples) and clinicopathologic correlation frameworks. Professional recognition includes: American Board of Pathology certification in Hematopathology (2022) American Board of Pathology certification in Anatomic & Clinical Pathology (2009) Dr. Dao actively contributes to academic leadership through committee service including Pathology Residency Clinical Competency Committee (2015-present), Pathology Residency Recruitment Committee (2011-2016), and Professional Development Sub-Committee (2013-2017). She maintains active membership in the Society for Hematopathology, American Society for Clinical Pathology, and College of American Pathologists.

• Hematopathology
• Surgical Pathology
• Amyloidosis Research
• +۳ مورد دیگر

Deborah J. Rubens is a Professor (Part-Time) in the Department of Imaging Sciences at the University of Rochester Medical Center, with a secondary appointment in Biomedical Engineering. She serves as Vice Chair for Faculty and Professional Development and Medical Director of the Rochester Center for Biomedical Ultrasound. Education : Biology (BS, Stanford University), Medicine (MD, University of Rochester) Board Certifications : Diagnostic Radiology Leadership : Former Director of Body MRI, Head of Ultrasound Division Her research focuses on ultrasound innovations including: Prostate cancer detection via sonoelasticity 3D ultrasound and contrast agent development US/MR/CT fusion imaging Shear wave dispersion for liver disease Telemedicine ultrasound applications in Peru She has led NIH-funded research on 3D ultrasound elastography and co-investigated studies on venous thrombosis prophylaxis. Scientific accolades include Fellowships in the American College of Radiology and American Institute of Ultrasound in Medicine, plus the Armed Forces Institute of Pathology Distinguished Scientist award. Her clinical expertise spans ultrasound, CT, and MRI diagnostics for genitourinary and hepatobiliary conditions.

• Medical Imaging
• Ultrasound
• Computed Tomography
• +۷ مورد دیگر

Margarita Revzin is an Associate Professor of Radiology and Biomedical Imaging at Yale School of Medicine , with expertise in vascular, abdominal, and gynecologic ultrasound, as well as emergency radiology. She contributes to advancing diagnostic techniques and education in medical imaging. Educational Background: Bachelor of Arts in Biology, New York University (1997) Master of Science in Molecular Cell Biology and Immunology, New York University (1999) MD, Pennsylvania State University College of Medicine (2003) Internship in Internal Medicine, Westchester County Medical Center (2004-2005) Residency in Diagnostic Radiology, Northwell Health (2005-2008) Fellowship in Abdominal and Interventional Imaging, Brigham and Women’s Hospital (2009) Research Interests focus on improving diagnostic accuracy in ultrasound applications for vascular, endocrine, and gynecological pathologies, alongside emergency radiology protocols. She is actively involved in developing imaging standards and educational resources. Leadership Roles: Vice President, New England Radiology Research Society (NERRS) Assistant Editor, Ultrasound in RadioGraphics Committee Member, RSNA, AIUM, SRU, SAR, ARRS, ACER, ACR Scientific Awards RSNA Honored Educator Award (3 times) Multiple Teaching Awards from Yale University School of Medicine Contributions include authoring peer-reviewed articles, book chapters, and educational abstracts, with a focus on ultrasound techniques, vascular anomalies, and emergency radiology. She is certified in Diagnostic Radiology by the American Board of Radiology and holds fellowships from the Society of Radiologists in Ultrasound (SRU) and the American Institute of Ultrasound in Medicine (AIUM).

• Radiology
• Biomedical Imaging
• Ultrasound
• +۵ مورد دیگر

Sara E. Wobker, MD, MPH, is an Associate Professor in both the Department of Pathology and Laboratory Medicine and the Department of Urology at the University of North Carolina at Chapel Hill . She also serves as Director of Anatomic Pathology , Director of Genitourinary Pathology , and Director of Surgical Pathology . Her research focuses on genitourinary malignancies , particularly the molecular characterization of rare variants of bladder carcinoma . She aims to translate histologic findings into molecular discoveries to improve patient care, with a recent emphasis on tumor microenvironment dynamics and immunotherapy response mechanisms in muscle-invasive bladder cancer. Analysis of her 15 most recent articles (2024-2021) reveals a strong trend in immunotherapy response , molecular subtyping , and diagnostic standardization for genitourinary cancers. Key subfields include FGFR inhibition , TFE3 gene fusions , clinicogenomic features , and pathology protocol optimization . Scientific Awards UNC Junior Faculty Development Award (2018-2019) As Faculty Director of the Pathology Services Core, she supports clinical trials , translational studies , and basic science research . She collaborates extensively with interdisciplinary teams in the UNC Lineberger Comprehensive Cancer Center, contributing to updates in renal and prostate cancer grading through the Genitourinary Pathology Society (GUPS).

• Genitourinary Pathology
• Molecular Characterization of Cancers
• Bladder Cancer Research
• +۳ مورد دیگر